Insights Into UiPath (PATH) Q1: Wall Street Projections for Key Metrics

Analysts anticipate UiPath's (PATH) upcoming earnings report to show a 23.1% year-over-year decline in EPS to $0.10 and a 0.8% decrease in revenue to $332.33 million. Key metrics forecasts include 'Revenue-Licenses' at $115.46 million, a 17.6% decrease year-over-year, ARR at $1.69 billion, and 'Net New ARR' at $22.09 million, significantly lower than the $44 million reported in the same quarter last year. UiPath holds a Zacks Rank #3 (Hold), suggesting market-average performance in the near term, despite its shares increasing 9% in the past month, underperforming the S&P 500's 10.7% gain.

Analysis

UiPath (PATH) is poised to release Q1 results that analysts anticipate will reflect notable headwinds. Projections indicate earnings per share of $0.10, a significant 23.1% decrease year-over-year, and total revenues of $332.33 million, representing a 0.8% decline compared to the same period last year. The consensus EPS estimate has not seen any revisions over the last 30 days, suggesting analyst conviction in these subdued figures. Further scrutiny of key metrics reveals expectations for 'Revenue- Licenses' to be $115.46 million, a substantial 17.6% drop year-over-year. While 'Annualized Recurring Revenue' (ARR) is forecasted to reach $1.69 billion, an increase from the $1.51 billion reported a year ago, the 'Net New ARR' is projected at a sharply lower $22.09 million, compared to $44 million in the prior-year quarter. This slowdown in new ARR acquisition is a critical indicator. Over the past month, UiPath's shares have gained 9%, yet this performance trails the Zacks S&P 500 composite's 10.7% rise. The stock currently holds a Zacks Rank #3 (Hold), implying its near-term performance may largely mirror the broader market.

Key Decisions for Investors

• Investors should closely monitor UiPath's upcoming Q1 earnings report, paying particular attention to the drivers behind the forecasted 23.1% EPS decline and the significant contraction in 'Net New ARR' to $22.09 million from $44 million year-over-year.
• Given the projected year-over-year decreases in key metrics such as 'Revenue-Licenses' (down 17.6%) and overall revenue (down 0.8%), alongside a neutral Zacks Rank #3 (Hold), a cautious stance is advisable, and evaluating the company's commentary on future growth drivers will be crucial.
• While the growth in total ARR to an expected $1.69 billion offers some positive signal, the sharp deceleration in the rate of new ARR acquisition and license revenue warrants careful consideration as these are pivotal for sustaining long-term growth and market penetration.